Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
January 10th, 2022
Close Date
November 15th, 2024
Opportunity No.
RFA-DA-22-037

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health is offering a grant opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)". This grant aims to support innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors, prevention of drug use and HIV, and health service utilization. The grant encourages the analysis of public use and other extant community-based or clinical datasets to increase our knowledge of drug using behaviors and their consequences, as well as strategies for prevention and treatment of drug abuse and HIV. The grant does not require cost sharing or matching. The deadline for application submission is November 15, 2024. For more information and to apply, please visit the following link: Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional).

Description

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)". This grant aims to support innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors, prevention of drug use and HIV, and health service utilization. The grant encourages the analysis of public use and other extant community-based or clinical datasets to increase our knowledge of drug using behaviors and their consequences, as well as strategies for prevention and treatment. The grant has a funding ceiling of $275,000 and does not require cost sharing or matching. The deadline for applications is November 15, 2024. For more information and to apply, visit the following link: [Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)](http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-037.html).
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)". This grant aims to support pilot, feasibility, or exploratory research in substance use epidemiology and health services. The research will focus on five priority areas, including responses to sudden and severe emerging drug issues, responses to emerging marijuana trends and topics related to the shifting policy landscape, responses to unexpected and time-sensitive prescription drug abuse research opportunities, responses to unexpected and time-sensitive medical system issues, and responses to unexpected and time-sensitive criminal or juvenile justice opportunities that relate to drug abuse and access and provision of health care service. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities, U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Institutions) and non-domestic components of U.S. Organizations are not eligible to apply. The grant does not require cost sharing or matching requirements. The funding instrument type is a grant, and the category of funding activity is health. The maximum award ceiling is $275,000. The deadline for application submission is September 8, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-027.html). If you have any inquiries, you can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.